NYVAC-C

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNYVAC-C
Drug Alias NameNYVAC poxvirus vector + clade C gag-pol-nef + env immunogenNYVAC-CNYVAC-HIV-C
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandFrance
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGeneartSanofiUniversity Of Regensburg +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneartEurovaccSanofi +[4] 
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A